0001145549-24-006270.txt : 20240213 0001145549-24-006270.hdr.sgml : 20240213 20240213170000 ACCESSION NUMBER: 0001145549-24-006270 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231130 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 EFFECTIVENESS DATE: 20240213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN FUNDS INFLATION LINKED BOND FUND CENTRAL INDEX KEY: 0001553197 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22746 FILM NUMBER: 24627520 BUSINESS ADDRESS: STREET 1: 6455 IRVINE CENTER DRIVE CITY: IRVINE STATE: CA ZIP: 92618-4518 BUSINESS PHONE: 800-421-4225 MAIL ADDRESS: STREET 1: 6455 IRVINE CENTER DRIVE CITY: IRVINE STATE: CA ZIP: 92618-4518 0001553197 S000039115 AMERICAN FUNDS INFLATION LINKED BOND FUND C000120322 Class A BFIAX C000120323 Class 529-F-1 CNLFX C000120324 Class R-1 RILAX C000120325 Class R-2 RILBX C000120326 Class R-3 RILCX C000120327 Class R-4 RILDX C000120328 Class R-5 RILEX C000120329 Class R-6 RILFX C000120331 Class C BFICX C000120332 Class F-1 BFIFX C000120333 Class F-2 BFIGX C000120334 Class 529-A CNLAX C000120336 Class 529-C CNLCX C000120337 Class 529-E CNLEX C000148371 Class R-2E RILGX C000164814 Class R-5E RILHX C000179978 Class F-3 FILBX C000189425 Class 529-T TLIBX C000189426 Class T TILBX C000224603 Class 529-F-2 FIBLX C000224604 Class 529-F-3 FLIBX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001553197 XXXXXXXX true false false N-1A true AMERICAN FUNDS INFLATION LINKED BOND FUND 811-22746 0001553197 549300C4MMT7NIUIFI59 6455 Irvine Center Drive Irvine 92618 US-CA US 9499755000 Capital Research and Management Company 6455 Irvine Center Drive Irvine 92618 9499755000 Fund accounting and transaction settlement records N N N-1A 1 Y Alexandra Trower N/A N Francisco G. Cigarroa N/A N Jennifer C. Feikin N/A N Karl J. Zeile N/A Y Leslie Stone Heisz N/A N Margaret Spellings N/A N Mary Davis Holt N/A N Merit E. Janow N/A N Michael C. Gitlin N/A Y Nariman Farvardin N/A N Paul S. Williams N/A N Jane M. Scofield N/A 333 South Hope Street 55th Floor Los Angeles 90071 XXXXXX N N N N N N American Funds Distributors, Inc. 8-17168 000006247 N/A Y N PricewaterhouseCoopers LLP 00238 5493002GVO7EO8RNNS37 N N N N N N N AMERICAN FUNDS INFLATION LINKED BOND FUND S000039115 549300C4MMT7NIUIFI59 N 21 0 0 N/A N N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-4 (17 CFR 270.12d1-4) Rule 18f-4 (17 CFR 270.18f-4) Rule 18f-4(f)(17 CFR 270.18f-4(f)) N N N N Capital Research and Management Company 801-8055 000110885 M02M7XSKLMK96MWKNF95 N American Funds Service Company 84-00316 N/A Y N N Refinitiv US LLC 213800HQORQAP68CJJ04 N Six Financial Information AG 506700D369548LQDC335 CH N Bloomberg L.P. 549300B56MD0ZC402L06 N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Virtu ITG Solutions Network, LLC N/A N Markit North America, Inc. 549300HLPTRASHS0E726 N N State Street Bank and Trust Co. N/A N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) The Hongkong and Shanghai Banking Corporation Limited N/A JP N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Banco Nacional de Mexico, S.A. N/A MX N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) State Street Bank and Trust Company, United Kingdom branch N/A GB N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N American Funds Service Company 84-00316 SEC File number Y N N Capital Research and Management Company M02M7XSKLMK96MWKNF95 Y N N American Funds Distributors, Inc. 8-17168 000006247 N/A 0.0 0.000000000000 J.P. Morgan Securities LLC 8-35008-1 000000079 ZBUT11V806EZRVTWT807 893063641.000000000000 Citigroup Global Markets Inc. 8-08177-1 000007059 MBNUM2BPBDO7JBLYG310 351955386.000000000000 Morgan Stanley & Co. LLC 8-15869-1 000008209 9R7GPTSO7KV3UQJZQ078 331521753.000000000000 Bank of America, N.A. 8-69787-1 000283942 B4TYDEB6GKMZO031MB27 326733821.000000000000 Barclays Bank PLC N/A N/A G5GSEF7VJP5I7OUK5573 GB 234536223.000000000000 BMO Capital Markets Corp. 8-34344-1 000016686 RUC0QBLBRPRCU4W1NE59 124278591.000000000000 Goldman Sachs & Co. LLC 8-00129-1 000000361 FOR8UP27PHTHYVLBNG30 112303890.000000000000 Citadel Securities Institutional LLC N/A N/A 549300MLQ1S3715IUK04 80645232.000000000000 Deutsche Bank A.G. N/A N/A 7LTWFZYICNSX8D621K86 DE 74518448.000000000000 Societe Generale N/A N/A O2RNE8IBXP4R0TD8PU41 FR 57874257.000000000000 2694884896.000000000000 N 13491574754.000000000000 Uncommitted 1500000000.000000000000 N N N N true INTERNAL CONTROL RPT 2 internalcontrolilbf.htm ILBF INTERNAL CONTROL REPORT - 11/30/2023 PDFtoHTML Conversion Output

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of American Funds Inflation Linked Bond Fund

In planning and performing our audit of the financial statements of American Funds Inflation Linked Bond Fund (the "Fund") as of and for the year ended November 30, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of November 30, 2023.

This report is intended solely for the information and use of the Board of Trustees of American Funds Inflation Linked Bond Fund and12 the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

Los Angeles, California

January 10, 2024

PricewaterhouseCoopers LLP, 601 South Figueroa Street, Los Angeles, CA 90017

T: (213) 356-6000, F: (813) 637 4444, www. pwc.com/us